Mas Ribo Alberto 4
4 · BECTON DICKINSON & CO · Filed Dec 18, 2019
Insider Transaction Report
Form 4
Mas Ribo Alberto
EVP and Pres, Life Sciences
Transactions
- Exercise/Conversion
Common Stock
2019-12-16$134.73/sh+12,153$1,637,374→ 27,739 total - Disposition to Issuer
Common Stock
2019-12-16$269.51/sh−6,068$1,635,387→ 21,671 total - Sale
Common Stock
2019-12-16$269.51/sh−11,860$3,196,389→ 9,811 total - Exercise/Conversion
Stock Appreciation Rights
2019-12-16−12,153→ 0 totalExercise: $134.73From: 2015-11-25Exp: 2024-11-25→ Common Stock (12,153 underlying)
Holdings
- 1,080(indirect: By Trust)
Common Stock
- 2,554(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $268.46 through $270.03. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Certain of the reported transactions were made pursuant to a 10b5-1 plan entered into on December 4, 2018.
- [F2]Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of May 31, 2019.
- [F3]Represents shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). The information presented for the SIP is as of May 31, 2019.
- [F4]The stock appreciation rights vest in four annual installments beginning November 25, 2015.